Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Jacobus Pharmaceutical reports development of novel antimalarials

Aug. 25, 2015

AAK1 inhibitor shows potential for the treatment of neuropathic pain

Aug. 24, 2015

Preclinical results presented for IKur inhibitor BMS-919373

Aug. 24, 2015

Novel aldosterone synthase inhibitors active in monkeys

Aug. 24, 2015

MAP/MAPKAP-2 inhibitor MK-2684 shows promise for the treatment of asthma

Aug. 21, 2015

Pan-Pim kinase inhibitors investgated at Amgen for anticancer activity

Aug. 21, 2015

LY-3130481: a TARPgamma8-dependent AMPA antagonist for epilepsy

Aug. 21, 2015

Alkeus provides update on ALK-001 for Stargardt disease

Aug. 20, 2015

Ocular-selective oral VEGFR-2 inhibitors for wet AMD reported by Novartis

Aug. 20, 2015

Amgen provides early preclinical data on TRPM8 antagonist for migraine

Aug. 20, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...